Capmatinib, 99.82%
cas: 1029712-80-8 — see every product listed under this CAS number, including other names
Capmatinib, 99.82% (CAS 1029712-80-8) is a chemical reagent available from Chemat. Available pack sizes: 10 mg, 25 mg, 50 mg, 100 mg, 10mM/1mL, 500 mg, 200 mg, 5 mg. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-13404-10 mg |
| cas | 1029712-80-8 |
| size | 10 mg |
| availability | In stock |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 10 mg | 491.52 Pln | |
| MedChemExpress | 25 mg | 677.28 Pln | |
| MedChemExpress | 50 mg | 839.82 Pln | |
| MedChemExpress | 100 mg | 1030.22 Pln | |
| MedChemExpress | 10mM/1mL | 412.57 Pln | |
| MedChemExpress | 500 mg | 2181.94 Pln | |
| MedChemExpress | 200 mg | 1271.71 Pln | |
| MedChemExpress | 5 mg | 384.71 Pln |
properties
| delivery time | 1-2 weeks |
|---|---|
| purity | 99.82% |
Capmatinib is a member of the class of imidazotriazines that is imidazo[1,2-b][1,2,4]triazine substituted by 3-fluoro-4-(methylcarbamoyl)phenyl and quinolin-6-ylmethyl groups at positions 2 and 7, respectively. It is a c-Met receptor tyrosine kinase inhibitor used for the treatment of non-small cell lung cancer with MET exon 14 skipping mutation. It has a role as an antineoplastic agent, a hepatotoxic agent, an apoptosis inducer and a c-Met tyrosine kinase inhibitor. It is a secondary carboxamide, a member of benzamides, a member of quinolines, an imidazotriazine and a member of monofluorobenzenes.
Source: ChEBI
| Molecular formula | C23H17FN6O |
|---|---|
| Molecular weight | 412.4 g/mol |
| IUPAC name | 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide |
| InChIKey | LIOLIMKSCNQPLV-UHFFFAOYSA-N |
| SMILES | CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F |
Computed by PubChem (NCBI)